Maxigen Biotech Inc. (TPE:1783)
42.95
0.00 (0.00%)
At close: Mar 6, 2026
-13.41% (1Y)
| Market Cap | 3.47B -23.0% |
| Revenue (ttm) | 792.49M +27.1% |
| Net Income | 234.07M +50.7% |
| EPS | 2.59 +49.6% |
| Shares Out | 80.69M |
| PE Ratio | 16.58 |
| Forward PE | n/a |
| Dividend | 0.83 (1.93%) |
| Ex-Dividend Date | Sep 5, 2025 |
| Volume | 75,200 |
| Average Volume | 94,066 |
| Open | 43.00 |
| Previous Close | 42.95 |
| Day's Range | 42.55 - 43.00 |
| 52-Week Range | 35.55 - 51.20 |
| Beta | 0.29 |
| RSI | 37.07 |
| Earnings Date | Mar 20, 2026 |